FeldmanAMMcNamaraD.Myocarditis. N Engl J Med. 2000;343:1388-1398.
2.
YajimaTKnowltonKU.Viral myocarditis: from the perspective of the virus. Circulation. 2009;119:2615-2624.
3.
UkenaCKindermannMMahfoudF. Diagnostic and prognostic validity of different biomarkers in patients with suspected myocarditis. Clin Res Cardiol. 2014;103:743-751.
4.
MolinaKMGarciaXDenfieldSW. Parvovirus B19 myocarditis causes significant morbidity and mortality in children. Pediatr Cardiol. 2013;34:390-397.
5.
SmithSCLadensonJHMasonJWJaffeAS.Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates. Circulation. 1997;95:163-168.
6.
KindermannIBarthCMahfoudF. Update on myocarditis. J Am Coll Cardiol. 2012;59:779-792.
7.
AndersonBRSilverESRichmondMELibermanL.Usefulness of arrhythmias as predictors of death and resource utilization in children with myocarditis. Am J Cardiol. 2014;114:1400-1405.
8.
Al-BiltagiMIssaMHagarHAAbdel-HafezMAzizNA.Circulating cardiac troponins levels and cardiac dysfunction in children with acute and fulminant viral myocarditis. Acta Pediatr. 2010;99:1510-1516.
9.
FreixaXSionisACastelA. Low troponin-I levels on admission are associated with worse prognosis in patients with fulminant myocarditis. Transplant Proc. 2009;41:2234-2236.